Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2018, Volume 33, Issue 9, pp. 1553 - 1555
Journal Article
JOURNAL OF BONE AND MINERAL RESEARCH, ISSN 0884-0431, 09/2018, Volume 33, Issue 9, pp. 1553 - 1555
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2017, Volume 69, Issue 4, pp. 395 - 403
Background The extent of coronary disease affects clinical outcomes and may predict the effectiveness of coronary revascularization with either coronary artery...
coronary disease | prognosis | stents | angiography | ischemia | surgery | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | BYPASS GRAFT-SURGERY | PROGNOSTIC VALUE | IMPACT | ANGIOPLASTY | CARDIAC-SURGERY | SYNERGY | TAXUS | INTERVENTION | CORONARY-ARTERY-DISEASE | Diabetes Complications - physiopathology | Humans | Middle Aged | Coronary Disease - physiopathology | Male | Treatment Outcome | Coronary Angiography | Coronary Disease - therapy | Coronary Artery Bypass | Female | Aged | Diabetes Complications - surgery | Retrospective Studies | Coronary Disease - surgery | Research Design | Percutaneous Coronary Intervention | Transluminal angioplasty | Coronary artery bypass | Cardiology | Coronary heart disease | Stroke | Heart surgery | Coronary vessels | Diabetes | Health risk assessment | Patients | Insulin
coronary disease | prognosis | stents | angiography | ischemia | surgery | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | BYPASS GRAFT-SURGERY | PROGNOSTIC VALUE | IMPACT | ANGIOPLASTY | CARDIAC-SURGERY | SYNERGY | TAXUS | INTERVENTION | CORONARY-ARTERY-DISEASE | Diabetes Complications - physiopathology | Humans | Middle Aged | Coronary Disease - physiopathology | Male | Treatment Outcome | Coronary Angiography | Coronary Disease - therapy | Coronary Artery Bypass | Female | Aged | Diabetes Complications - surgery | Retrospective Studies | Coronary Disease - surgery | Research Design | Percutaneous Coronary Intervention | Transluminal angioplasty | Coronary artery bypass | Cardiology | Coronary heart disease | Stroke | Heart surgery | Coronary vessels | Diabetes | Health risk assessment | Patients | Insulin
Journal Article
2003, ISBN 1842140302, 150
Book
Endocrine Practice, ISSN 1530-891X, 2016, Volume 22, Issue Suppl 4, pp. 1 - 42
The American Association of Clinical Endocrinologists/American College of Endocrinology Medical Guidelines for Practice are systematically developed statements...
VITAMIN-D SUPPLEMENTATION | BONE-MINERAL DENSITY | VERTEBRAL FRACTURE RISK | ZOLEDRONIC ACID TREATMENT | ENDOCRINOLOGY & METABOLISM | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | HORMONE REPLACEMENT THERAPY | ESTROGEN PLUS PROGESTIN | TREATMENT DECISION-MAKING | MONTHLY ORAL IBANDRONATE | Endocrinologists - standards | Osteoporosis, Postmenopausal - epidemiology | United States - epidemiology | Bone Density | Osteoporosis, Postmenopausal - diagnosis | Humans | Fractures, Bone - epidemiology | Osteoporosis, Postmenopausal - therapy | Fractures, Bone - diagnosis | Absorptiometry, Photon | Endocrinology - standards | Societies, Medical - organization & administration | Societies, Medical - standards | Fractures, Bone - prevention & control
VITAMIN-D SUPPLEMENTATION | BONE-MINERAL DENSITY | VERTEBRAL FRACTURE RISK | ZOLEDRONIC ACID TREATMENT | ENDOCRINOLOGY & METABOLISM | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | HORMONE REPLACEMENT THERAPY | ESTROGEN PLUS PROGESTIN | TREATMENT DECISION-MAKING | MONTHLY ORAL IBANDRONATE | Endocrinologists - standards | Osteoporosis, Postmenopausal - epidemiology | United States - epidemiology | Bone Density | Osteoporosis, Postmenopausal - diagnosis | Humans | Fractures, Bone - epidemiology | Osteoporosis, Postmenopausal - therapy | Fractures, Bone - diagnosis | Absorptiometry, Photon | Endocrinology - standards | Societies, Medical - organization & administration | Societies, Medical - standards | Fractures, Bone - prevention & control
Journal Article
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, ISSN 0889-8529, 06/1998, Volume 27, Issue 2, pp. 441 - 441
Although sodium fluoride is a potent stimulator of bone formation, a clear role for this therapy in osteoporosis remains elusive. Controlled clinical trials...
VITAMIN-D | WOMEN | POSTMENOPAUSAL OSTEOPOROSIS | THERAPY | PHOSPHATASE | CALCIUM | ENDOCRINOLOGY & METABOLISM | FRACTURE OCCURRENCE | HIP-FRACTURES | RELEASE SODIUM-FLUORIDE | BONE | Bone Density - drug effects | Sodium Fluoride - adverse effects | Sodium Fluoride - pharmacokinetics | Osteoporosis - prevention & control | Humans | Sodium Fluoride - therapeutic use
VITAMIN-D | WOMEN | POSTMENOPAUSAL OSTEOPOROSIS | THERAPY | PHOSPHATASE | CALCIUM | ENDOCRINOLOGY & METABOLISM | FRACTURE OCCURRENCE | HIP-FRACTURES | RELEASE SODIUM-FLUORIDE | BONE | Bone Density - drug effects | Sodium Fluoride - adverse effects | Sodium Fluoride - pharmacokinetics | Osteoporosis - prevention & control | Humans | Sodium Fluoride - therapeutic use
Journal Article
Treatments in Endocrinology, ISSN 1175-6349, 2005, Volume 4, Issue 6, pp. 379 - 379
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 4, pp. 395 - 403
Abstract Background The extent of coronary disease affects clinical outcomes and may predict the effectiveness of coronary revascularization with either...
Cardiovascular | Internal Medicine | coronary disease | prognosis | stents | angiography | ischemia | surgery | Transluminal angioplasty | Coronary artery bypass | Coronary heart disease | Medical imaging equipment
Cardiovascular | Internal Medicine | coronary disease | prognosis | stents | angiography | ischemia | surgery | Transluminal angioplasty | Coronary artery bypass | Coronary heart disease | Medical imaging equipment
Journal Article
1999, ISBN 0124126502, xv, 173
Book
Journal of Bone and Mineral Research, ISSN 0884-0431, 07/2012, Volume 27, Issue 7, pp. 1494 - 1500
This study compared microscopic magnetic resonance imaging (µMRI) parameters of trabecular microarchitecture between postmenopausal women with and without...
FRACTURE | TRABECULAR MICROARCHITECTURE | MAGNETIC RESONANCE IMAGING | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | Osteoporosis | Fracture | Postmenopausal women | Trabecular microarchitecture | Magnetic resonance imaging | BONE-MINERAL DENSITY | MAGNETIC-RESONANCE IMAGES | REVEALS STRUCTURAL IMPLICATIONS | COMPUTED-TOMOGRAPHY | CANCELLOUS BONE | DISTAL RADIUS | IN-VIVO | ENDOCRINOLOGY & METABOLISM | OSTEOPOROTIC FRACTURES | TOPOLOGICAL ANALYSIS | QUALITY-OF-LIFE | Bone and Bones - pathology | Bone Density | Prospective Studies | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Risk | Pilot Projects | Fracture Healing | Image Processing, Computer-Assisted | Postmenopause | Female | Aged | Fractures, Bone - therapy | Fractures, Bone - prevention & control | Dual energy X-ray absorptiometry | Radius | Femur | Spine (lumbar) | Bone (trabecular) | Post-menopause | Wrist | Fractures | Races | Risk assessment | Bone mineral density | Age | Geriatrics
FRACTURE | TRABECULAR MICROARCHITECTURE | MAGNETIC RESONANCE IMAGING | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | Osteoporosis | Fracture | Postmenopausal women | Trabecular microarchitecture | Magnetic resonance imaging | BONE-MINERAL DENSITY | MAGNETIC-RESONANCE IMAGES | REVEALS STRUCTURAL IMPLICATIONS | COMPUTED-TOMOGRAPHY | CANCELLOUS BONE | DISTAL RADIUS | IN-VIVO | ENDOCRINOLOGY & METABOLISM | OSTEOPOROTIC FRACTURES | TOPOLOGICAL ANALYSIS | QUALITY-OF-LIFE | Bone and Bones - pathology | Bone Density | Prospective Studies | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Risk | Pilot Projects | Fracture Healing | Image Processing, Computer-Assisted | Postmenopause | Female | Aged | Fractures, Bone - therapy | Fractures, Bone - prevention & control | Dual energy X-ray absorptiometry | Radius | Femur | Spine (lumbar) | Bone (trabecular) | Post-menopause | Wrist | Fractures | Races | Risk assessment | Bone mineral density | Age | Geriatrics
Journal Article
The Journal of Bone and Joint Surgery, ISSN 0021-9355, 06/2014, Volume 96, Issue 11, pp. e90 - e90
BACKGROUND:To gain insight into how teriparatide affects various bone health parameters, we assessed the effects of teriparatide treatment with use of standard...
Teriparatide - therapeutic use | United States | Humans | Middle Aged | Bone Density Conservation Agents - therapeutic use | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Osteoporosis - drug therapy | Treatment Outcome | Absorptiometry, Photon | Canada | Bone Density - drug effects | Osteoporosis - diagnostic imaging | Aged, 80 and over | Female | Finite Element Analysis | Aged
Teriparatide - therapeutic use | United States | Humans | Middle Aged | Bone Density Conservation Agents - therapeutic use | Magnetic Resonance Imaging - methods | Tomography, X-Ray Computed - methods | Osteoporosis - drug therapy | Treatment Outcome | Absorptiometry, Photon | Canada | Bone Density - drug effects | Osteoporosis - diagnostic imaging | Aged, 80 and over | Female | Finite Element Analysis | Aged
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 05/2008, Volume 3, Issue 3, pp. 836 - 843
1,25-Dihydroxyvitamin D-3 levels begin to drop early in the course of kidney disease, leading to elevated parathyroid hormone levels and disrupted mineral...
VITAMIN-D | AORTIC CALCIFICATION | CORONARY-ARTERY CALCIFICATION | PULSE-WAVE VELOCITY | PLASMA LEPTIN LEVELS | VASCULAR CALCIFICATION | 3RD NATIONAL-HEALTH | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | STAGE RENAL-DISEASE | PERITONEAL-DIALYSIS PATIENTS | Vitamin D Deficiency - complications | Cardiovascular Diseases - prevention & control | Humans | Hyperparathyroidism, Secondary - physiopathology | Vitamin D Deficiency - drug therapy | Vitamin D Deficiency - physiopathology | Bone Diseases, Metabolic - drug therapy | Hyperparathyroidism, Secondary - complications | Bone Demineralization, Pathologic - complications | Calcinosis - etiology | Bone Diseases, Metabolic - complications | Vitamin D Deficiency - etiology | Kidney Failure, Chronic - physiopathology | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Hyperparathyroidism, Secondary - drug therapy | Kidney Failure, Chronic - drug therapy | Risk Factors | Bone Diseases, Metabolic - etiology | Treatment Outcome | Bone Demineralization, Pathologic - etiology | Kidney Failure, Chronic - complications | Calcinosis - prevention & control | Bone Diseases, Metabolic - physiopathology | Hyperparathyroidism, Secondary - etiology | Bone Remodeling | Calcinosis - physiopathology
VITAMIN-D | AORTIC CALCIFICATION | CORONARY-ARTERY CALCIFICATION | PULSE-WAVE VELOCITY | PLASMA LEPTIN LEVELS | VASCULAR CALCIFICATION | 3RD NATIONAL-HEALTH | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | STAGE RENAL-DISEASE | PERITONEAL-DIALYSIS PATIENTS | Vitamin D Deficiency - complications | Cardiovascular Diseases - prevention & control | Humans | Hyperparathyroidism, Secondary - physiopathology | Vitamin D Deficiency - drug therapy | Vitamin D Deficiency - physiopathology | Bone Diseases, Metabolic - drug therapy | Hyperparathyroidism, Secondary - complications | Bone Demineralization, Pathologic - complications | Calcinosis - etiology | Bone Diseases, Metabolic - complications | Vitamin D Deficiency - etiology | Kidney Failure, Chronic - physiopathology | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Hyperparathyroidism, Secondary - drug therapy | Kidney Failure, Chronic - drug therapy | Risk Factors | Bone Diseases, Metabolic - etiology | Treatment Outcome | Bone Demineralization, Pathologic - etiology | Kidney Failure, Chronic - complications | Calcinosis - prevention & control | Bone Diseases, Metabolic - physiopathology | Hyperparathyroidism, Secondary - etiology | Bone Remodeling | Calcinosis - physiopathology
Journal Article
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 11/2010, Volume 16, pp. 1 - 37
Journal Article
Endocrine Practice, ISSN 1530-891X, 09/2016, Volume 22, Issue 9, pp. 1111 - 1117
AACE = American Association of Clinical Endocrinologists AFF = atypical femur fracture ASBMR = American Society for Bone and Mineral Research BEL = best...
Collagen Type I - blood | Bone Density | Osteoporosis, Postmenopausal - diagnosis | Evidence-Based Practice | United States | Humans | Osteoporotic Fractures - diagnosis | Endocrinology - organization & administration | Biomarkers - blood | Osteoporosis, Postmenopausal - therapy | Parathyroid Hormone - blood | Endocrinology - standards | Vitamin D - blood | Societies, Medical - organization & administration | Vitamin D - analogs & derivatives | Osteoporotic Fractures - therapy | Societies, Medical - standards
Collagen Type I - blood | Bone Density | Osteoporosis, Postmenopausal - diagnosis | Evidence-Based Practice | United States | Humans | Osteoporotic Fractures - diagnosis | Endocrinology - organization & administration | Biomarkers - blood | Osteoporosis, Postmenopausal - therapy | Parathyroid Hormone - blood | Endocrinology - standards | Vitamin D - blood | Societies, Medical - organization & administration | Vitamin D - analogs & derivatives | Osteoporotic Fractures - therapy | Societies, Medical - standards
Journal Article
JAMA, ISSN 0098-7484, 05/2002, Volume 287, Issue 20, pp. 2668 - 2676
CONTEXT Lower-than-commonly-prescribed doses of conjugated equine estrogens (CEEs) with medroxyprogesterone acetate (MPA) improve vasomotor symptoms and...
DENSITY | MEDICINE, GENERAL & INTERNAL | CONTROLLED TRIAL | ENDOMETRIUM | METABOLISM | PREVENTION | HORMONE REPLACEMENT THERAPY | LIPOPROTEINS | OSTEOPOROSIS | RANDOMIZED TRIAL | LIPIDS | Estrogen Replacement Therapy | Estrogens, Conjugated (USP) - pharmacology | Double-Blind Method | Peptides - urine | Humans | Middle Aged | Medroxyprogesterone Acetate - pharmacology | Collagen Type I | Bone Remodeling - drug effects | Osteocalcin - blood | Bone Density - drug effects | Collagen - urine | Progesterone Congeners - pharmacology | Biomarkers | Postmenopause | Adult | Female | Bones | Dosage and administration | Hormone therapy | Density | Estrogen | Clinical trials | Drug therapy | Menopause
DENSITY | MEDICINE, GENERAL & INTERNAL | CONTROLLED TRIAL | ENDOMETRIUM | METABOLISM | PREVENTION | HORMONE REPLACEMENT THERAPY | LIPOPROTEINS | OSTEOPOROSIS | RANDOMIZED TRIAL | LIPIDS | Estrogen Replacement Therapy | Estrogens, Conjugated (USP) - pharmacology | Double-Blind Method | Peptides - urine | Humans | Middle Aged | Medroxyprogesterone Acetate - pharmacology | Collagen Type I | Bone Remodeling - drug effects | Osteocalcin - blood | Bone Density - drug effects | Collagen - urine | Progesterone Congeners - pharmacology | Biomarkers | Postmenopause | Adult | Female | Bones | Dosage and administration | Hormone therapy | Density | Estrogen | Clinical trials | Drug therapy | Menopause
Journal Article
Aging Cell, ISSN 1474-9718, 02/2011, Volume 10, Issue 1, pp. 96 - 102
Summary Calorie restriction (CR) reduces bone quantity but not bone quality in rodents. Nothing is known regarding the long‐term effects of CR with adequate...
bone mineral density | bone turnover | calorie restriction | bone quality | high‐resolution magnetic resonance imaging | trabecular bone microarchitecture | Bone quality | Bone mineral density | Bone turnover | Trabecular bone microarchitecture | High-resolution magnetic resonance imaging | Calorie restriction | CORTICAL BONE | high-resolution magnetic resonance imaging | MECHANICAL-PROPERTIES | OSTEOPOROSIS | INFLAMMATORY MARKERS | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | TRABECULAR BONE | HIP FRACTURE | VERTEBRAL FRACTURE RISK | FEMALE RATS | POSTMENOPAUSAL WOMEN | T-CELLS | Body Composition | Body Mass Index | Collagen Type I - blood | Nutritional Requirements | Peptides - blood | Bone and Bones - physiology | Bone Density - physiology | Bone and Bones - chemistry | Cross-Sectional Studies | Caloric Restriction | Humans | Middle Aged | Risk Factors | Male | Time | Magnetic Resonance Imaging | Hip - physiology | Female | C-Reactive Protein - analysis | Alkaline Phosphatase - blood | Fractures, Bone - prevention & control
bone mineral density | bone turnover | calorie restriction | bone quality | high‐resolution magnetic resonance imaging | trabecular bone microarchitecture | Bone quality | Bone mineral density | Bone turnover | Trabecular bone microarchitecture | High-resolution magnetic resonance imaging | Calorie restriction | CORTICAL BONE | high-resolution magnetic resonance imaging | MECHANICAL-PROPERTIES | OSTEOPOROSIS | INFLAMMATORY MARKERS | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | TRABECULAR BONE | HIP FRACTURE | VERTEBRAL FRACTURE RISK | FEMALE RATS | POSTMENOPAUSAL WOMEN | T-CELLS | Body Composition | Body Mass Index | Collagen Type I - blood | Nutritional Requirements | Peptides - blood | Bone and Bones - physiology | Bone Density - physiology | Bone and Bones - chemistry | Cross-Sectional Studies | Caloric Restriction | Humans | Middle Aged | Risk Factors | Male | Time | Magnetic Resonance Imaging | Hip - physiology | Female | C-Reactive Protein - analysis | Alkaline Phosphatase - blood | Fractures, Bone - prevention & control
Journal Article
Clinical Chemistry, ISSN 0009-9147, 09/2011, Volume 57, Issue 9, pp. 1227 - 1232
Separate estimates for 25-OHD2 and 25-OHD3-together with recent food- and supplement-intake data, questionnaire data about physical activity, sunprotection...
MEDICAL LABORATORY TECHNOLOGY | Malabsorption Syndromes - diagnosis | Sarcoidosis - diagnosis | Diagnosis, Differential | Renal Insufficiency - diagnosis | Calcifediol - blood | Humans | Osteoporosis - diagnosis | Reference Values | Receptors, Calcitriol - genetics | Polymorphism, Genetic | Sunscreening Agents - administration & dosage | Vitamin D - blood | Clinical Laboratory Techniques - methods | Vitamin D Deficiency - diagnosis | Ergocalciferols - blood | Vitamin D - analogs & derivatives | Dietary Supplements | Technology application | Calcifediol | Alfacalcidol | Vitamin D | Celiac disease | Disease | Sarcoidosis | Winter | Metabolites | Older people | Vitamin deficiency | Mass spectrometry | Methods | Food
MEDICAL LABORATORY TECHNOLOGY | Malabsorption Syndromes - diagnosis | Sarcoidosis - diagnosis | Diagnosis, Differential | Renal Insufficiency - diagnosis | Calcifediol - blood | Humans | Osteoporosis - diagnosis | Reference Values | Receptors, Calcitriol - genetics | Polymorphism, Genetic | Sunscreening Agents - administration & dosage | Vitamin D - blood | Clinical Laboratory Techniques - methods | Vitamin D Deficiency - diagnosis | Ergocalciferols - blood | Vitamin D - analogs & derivatives | Dietary Supplements | Technology application | Calcifediol | Alfacalcidol | Vitamin D | Celiac disease | Disease | Sarcoidosis | Winter | Metabolites | Older people | Vitamin deficiency | Mass spectrometry | Methods | Food
Journal Article
Endocrine Practice, ISSN 1530-891X, 2010, Volume 16, Issue 6, pp. 1016 - 1019
Journal Article
Expert Review of Endocrinology & Metabolism, ISSN 1744-6651, 03/2010, Volume 5, Issue 2, pp. 165 - 167
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.